Haplobanking induced pluripotent stem cells for clinical use

Haplobanking induced pluripotent stem cells for clinical use

The development of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka and colleagues in 2006 has led to a potential new paradigm in cellular therapeutics, including the possibility of producing patient-specific, disease-specific and immune matched allogeneic cell therapies. One can envisage t...

Full description

Bibliographic Details
Main Authors: Stephen Sullivan, Paul J. Fairchild, Steven G.E. Marsh, Carlheinz R. Müller, Marc L. Turner, Jihwan Song, David Turner
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506120303366

Internet

http://www.sciencedirect.com/science/article/pii/S1873506120303366

Similar Items